Introduction
Temporal Lobe Epilepsies (TLE) are fascinating conditions as they raise fundamental questions about brain development, neuroplasticity, molecular-and genetic pathways of epileptogenesis and mechanisms of pharmacoresistance. The term TLE simply refers to the location where seizures arise and does not allude to a common pathogenesis. Yet, TLE consist of several entities with different etiological backgrounds.
Despite recent medical advances patients with TLE continue to frequently display pharmacoresistance and often require temporal lobectomy to achieve seizure control. 1 Thus there is an urgent need to develop new therapy strategies for TLE. One of the most important future tasks to overcome medical intractability is to identify distinguishable entities among the TLE and tailor pharmacological treatment to the respective. Delineation of subgroups is however challenging as they exhibit similar phenotypes and are determined by complex polygenetic inheritance and largely unidentified environmental factors.
There is a growing list of indications in literature that TLE patients who suffered from febrile seizures in early childhood (TLE-FS) constitute a unique entity distinct from afebrile TLE. [2] [3] [4] In fact, studies on several large pedigrees suggest that TLE and FS may have a common genetic basis, whether hippocampal sclerosis is present or not. [5] [6] [7] These studies are reinforced by data from our recent association study that indicates genetic variants in TLE-FS. 8 In this respect the question arises whether TLE-FS display a phenotype that can be distinguished from other TLE. To address this issue, we here perform a comparative analysis of two TLE patient cohorts -one cohort with FS and one without FS -in order to identify phenotypic characteristics associated with TLE-FS. This is the first study to systematically investigate clinical characteristics of patients with TLE-FS. 
Materials and methods

Patient collection
Patient data were collected between 2000 and 2004 in a cooperative project (GenEpA), involving only tertiary Norwegian centers with high competence in the field of epileptology. 207 patients with TLE (according to the ILAE criteria, see www.ilae.org) were included. Inclusion criteria for all individuals were: age > 18 years; Caucasian race, with at least 3 of 4 grandparents of Scandinavian origin. Patients filled out standardized evaluation forms together with the treating physician or epilepsy nurse. These forms were controlled by the treating epileptologist and lacking information was added based on the medical records. MRI (typically 1 or 1.5 T, with sagittal and axial T1, axial and coronal T2 and FLAIR) was performed in all patients in order to identify abnormalities such as hippocampal sclerosis, temporal lobe atrophy and mass lesions. TLE patients with FS were compared with those patients without FS. We analyzed patient data as age, sex, age at epilepsy onset, incidence of FS in first grade family members, incidence of hippocampal sclerosis or other abnormalities in MRI, and clinical characteristics as seizure semiology and other ictal and interictal symptoms.
Data analysis
Categorical variables were described with proportions, continuous with median and range. Associations between variables were studied using Chi-square tests or Fisher's exact tests (when number of observations was too small for one or both variables). Crude association between the two patient subgroups and age of epilepsy onset were assessed using Cochran-Armitage test for trend. 9 To correct for possible confounding caused by overrepresentation of MTLE-HS in TLE-FS, multiple logistic regression models were adjusted for MTLE-HS and the results expressed as odds ratios (OR) with 95% confidence intervals (CI). pValues < 0.05 were considered statistically significant. All analyses were computed using SPSS, ver.16.
Results
Patient characteristics
Age at epilepsy onset was lower in patients with TLE-FS (p < 0.001) (Fig. 1) . Patients with MTLE-HS were overrepresented in the TLE-FS group (p = 0.043). TLE-FS patients had more than three times higher frequency of first grade family members with childhood febrile seizures (p = 0.003, adjusted for MTLE-HS: OR 3.85; 95% CI 1.66-8.9). Further patient characteristics are summarized in Table 1 .
Ictal and interictal features
TLE-FS patients were more frequently plagued with simple partial seizures (p = 0.015, adjusted OR 1.87; 95% CI 1.04-3.37), and especially with vertiginous symptoms (p = 0.004 adjusted OR 6.04; 95% CI 1.66-21.92) and psychic symptoms as dé jà vu, jamais vu and ictal fear (p = 0.047). They also had the higher frequency of ictal autonomic symptoms (p = 0.003; adjusted OR 2.2, 95% CI 1.2-4.1), and displayed more often generalized tonic-clonic seizures (0.034; adjusted OR 2.5, 95% CI 1.1-6.4). Ictal features are summarized in Table 2 . Interictally, TLE-FS patients showed borderline more often abnormal psychiatric or cognitive behavior (mood disturbance, psychosis, anxiety, cognitive impairment or memory disturbance) (p = 0.046), but reached no statistical significance when corrected for MTLE-HS.
Discussion
It is a contemporary phenomenon that diseases from traditionally having been subdivided on the basis of their clinical features increasingly become defined by their genetic background. Therefore, current disease classifications often appear confusing due to inclusion of both clinical and genetic information. The TLE usually have been subdivided on the basis of their electroclinical pattern into neocortical TLE (NTLE) and mesial TLE (MTLE), the latter further in MTLE with (MTLE-HS) and without hippocampal sclerosis. The latest proposal for classification of epileptic syndromes by the International League Against Epilepsy (ILAE) highlights only two distinctive subgroups among the TLE, which are familial MTLE (FMTLE) and MTLE-HS 10 ; the first is defined by its specific genetic background, the second on the basis of its typical clinical presentation. Additionally the classification exhibits a third term, ''MTLE defined by specific etiologies'', to encourage further subdivision. As mentioned in the introduction, subdivision may contribute to challenge pharmacoresistant TLE. The present study was motivated by findings from our recent association study that indicated genetic variation among TLE patients who have had febrile seizures in childhood (TLE-FS) when compared with TLE without FS. 8 As a result of our findings we wanted to test the hypothesis that TLE-FS may display another subgroup among the TLE. This hypothesis is supported by other studies that have indicated TLE-FS to constitute a unique entity distinct from afebrile TLE. [2] [3] [4] In this respect the question arises whether TLE-FS present clinical characteristics that allow a
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Age onset afebrile seizures 28 23 distinction from other TLE. Surprisingly we could not detect any previous study in which the phenotype of TLE-FS has been systematically investigated. Our study shows that age at afebrile seizure onset is significantly lower in TLE-FS than in the other TLE patients. Generally, age at disease onset is an important indicator that facilitates delineation of disorders. Early epilepsy onset is consistent with particular biological features in the maturing brain that contribute to its hyperexcitability. [11] [12] [13] In certain epileptic conditions, such as probably in TLE-FS, a pathological reinforcement of these age-specific factors may predispose to seizure susceptibility in an early phase of development. TLE patients with FS also seem to have a more serious condition than those without FS, as they display higher seizure frequency for both partial and generalized seizures, and surgery (vagus nerve stimulator and temporal lobectomy) tended to be more often conducted. Additionally we observed the higher incidence of ictal autonomic symptoms, vertiginous symptoms, psychic symptoms, but we have no good explanation for these observations. Not surprising, we found that patients with MTLE-HS were overrepresented in the TLE-FS group. As patients with MTLE-HS are known to present a typical clinical picture, 14 we conducted logistic regression analysis (LRA) to adjust for probable confounders caused by the overrepresentation of MTLE-HS in the TLE-FS group. LRA confirmed our original findings and thus strengthened the idea of TLE-FS to represent a distinctive phenotype. Certainly, one could ask whether it makes sense to divide TLE-FS from MTLE-HS as it is supposed that there is a large overlap. On the other hand it is still one of the most controversial topics whether febrile seizures are associated with TLE; some studies confirm such a link, [15] [16] [17] while others proof the opposite. 18, 19 At least, TLE-FS patients had the higher frequency of first grade family members with childhood febrile seizures. Febrile Seizures have principally been regarded as genetically determined, as twinand family studies have pointed to an important genetic component 20, 21 and epidemiological studies have shown a regional variation in prevalence. 22 27 and also, if somewhat controversial, the high association with febrile seizures. 28 The most recent findings have added important information to the rigid concepts of the TLE field and should be taken into consideration: First, boundaries between simple-and complex FS are more fluid than earlier predicted and the assumption that only complex FS may lead to hippocampal injury followed by TLE is no longer adequate, as even simple FS may cause hippocampal abnormalities and TLE. 29, 30 Second, it became more obvious that only a fraction of patients with complex FS develop TLE
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; and third, patients with FMTLE may not only develop complex, but also simple FS. The last finding, even originating only from a few families, fits nicely into the scope of our study as it demonstrates a coupling between a reliable genetic background responsible for both complex and simple febrile seizures and a clear relation to TLE. 32, 33 Our data were collected from a relatively small and homogenous population from Norway, which is usually considered an advantage. However, there may be geographical variations of FS etiology, based on different genetic and environmental factors around the world. Additional trials are therefore required to verify our results. Furthermore, the type of epilepsy that develops after FS depends on a variety of factors, of which some may be genetic; others may include characteristics of the FS themselves. Recent studies on animal models have demonstrated that FS seem to activate cellular and molecular mechanisms that may have an impact on the clinical characteristics of the TLE phenotype. 34 Furthermore, pathogenic factors of FS such as inflammation ''at a certain time in a certain place'' in the brain doubtlessly have an influence on the phenotype by affecting anatomy and physiology, regardless genetics. 35 Although no genes have been found for the vast majority of FS and TLE, there is a growing consensus that genetics plays a role in both conditions. As containing two strong clinical features, the combination of TLE plus childhood FS may be a predictor for a genetic basis itself, and it is therefore reasonable to search for susceptibility genes and also phenotypic characteristics in the intersection of both conditions. Indeed, we identified TLE-FS as a phenotype that can be delineated from other TLE. None of the characteristics are specific, but we disclosed a subset of features. Further research including genetic, clinical and animal studies, are however needed to settle our results.
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